WSHA’s response to ARRIVE trial

March 21, 2018

In February, the abstract from the ARRIVE trial — a multi-center randomized controlled trial comparing induction of labor at 39 weeks gestation with expectant management of labor in first-time mothers —was presented at the annual Society for Maternal-Fetal Medicine (SMFM) conference in Dallas, Texas.

While the findings presented indicate that cesarean birth rates were lower in the induction group (18.6%) than the expectant management group (22.2%) without causing a statistically significant increase in adverse perinatal outcomes, WSHA’s Safe Deliveries Roadmap encourages all our member hospitals to continue to promote the current labor management guidelines (ACOG, SMFM, BREE collaborative & Safe Deliveries Roadmap: Labor Bundle).

We encourage continuing to follow these recommendations until the ARRIVE trial has been formally published and reviewed for its strengths, limitations and clinical implications.

See the ARRIVE trial abstract.

Selected partner responses to the ARRIVE trial:

You can also watch the 18-minute late-breaking presentation at SMFM. (Amber Weiseth)


Contact Us

Washington State Hospital Association
999 Third Avenue
Suite 1400
Seattle, WA 98104

Map / Directions

206.281.7211 phone
206.283.6122 fax

Staff List